Association Between Monoclonal Gammopathy of Undetermined Significance and Cardiovascular Disease Risk: A Veterans Health Administration Study
Journal of the American Heart Association · 2026
DOI: 10.1161/jaha.125.042187 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Journal of the American Heart Association, 2026. Verfasst von Tzeyu L Michaud und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Health Promotion, College of Public Health University of Nebraska Medical Center Omaha NE USA. Hauptthemen laut MEDLINE: Cardiovascular Diseases, Monoclonal Gammopathy of Undetermined Significance, Veterans Health. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS.
Abstract (Originalsprache)
Background
Monoclonal gammopathy of undetermined significance (MGUS) is associated with an increased risk of cardiovascular disease (CVD). However, its potential to provide additional prognostic information beyond traditional CVD risk assessments remains unknown. This study aimed to examine the association between MGUS and incident CVD and to determine whether MGUS status offers additional prognostic value beyond the established atherosclerotic cardiovascular disease risk calculation.
Methods
We conducted a retrospective, matched observational study using 2010 to 2021 Veterans Health Administration data. MGUS status, confirmed through a validated natural language processing algorithm, were 1:5 matched to individuals without MGUS. The outcome of interest was an incident CVD event. Cumulative incidence functions were compared using Gray’s test. Multivariable Fine and Gray’s subdistribution models were performed to estimate the adjusted hazard ratios (aHRs) for incident CVD. Analyses were also stratified by atherosclerotic CVD risk category (low/borderline, intermediate, high).
Results
The analytic cohort included 70 320 individuals (11 720/58 600 with/without MGUS); MGUS was associated with a higher 10‐year CVD incidence (29.5% versus 9.7%; P
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Health Promotion, College of Public Health University of Nebraska Medical Center Omaha NE USA.
- Center for Reducing Health Disparities, College of Public Health University of Nebraska Medical Center Omaha NE USA.
- Research Service St. Louis Veterans Affairs Medical Center St. Louis MO USA.
- Division of Public Health Sciences, Department of Surgery Washington University School of Medicine St. Louis MO USA.
- Durham Veterans Affairs Health Care System Durham NC USA.
- Duke University School of Medicine Durham NC USA.
ORCID-Profile: Tzeyu L Michaud, Mei Wang, Lawrence Liu, Kristen M Sanfilippo, Graham A Colditz, Martin W Schoen, Su-Hsin Chang
Förderung
- NCI NIH HHS
Zitieren
APA
Michaud, T. L., Wang, M., Friedman, D. R., Liu, L., Thomas, T. S., Sanfilippo, K. M., Colditz, G. A., Schoen, M. W., & Chang, S. H. (2026). Association Between Monoclonal Gammopathy of Undetermined Significance and Cardiovascular Disease Risk: A Veterans Health Administration Study. Journal of the American Heart Association. https://doi.org/10.1161/jaha.125.042187
Vancouver
Michaud TL, Wang M, Friedman DR, Liu L, Thomas TS, Sanfilippo KM, et al. Association Between Monoclonal Gammopathy of Undetermined Significance and Cardiovascular Disease Risk: A Veterans Health Administration Study. Journal of the American Heart Association. 2026. doi:10.1161/jaha.125.042187
BibTeX
@article{Michaud2026,
author = {Michaud, Tzeyu L and Wang, Mei and Friedman, Daphne R and Liu, Lawrence and Thomas, Theodore S and Sanfilippo, Kristen M and Colditz, Graham A and Schoen, Martin W and Chang, Su-Hsin},
title = {Association Between Monoclonal Gammopathy of Undetermined Significance and Cardiovascular Disease Risk: A Veterans Health Administration Study},
journal = {Journal of the American Heart Association},
year = {2026},
doi = {10.1161/jaha.125.042187}
}
EUVIMED